Application of Recent Guidance on Missing Data to Truncated Immunogenicity Data
 View Presentation
*John Jezorwski, Sanofi Pasteur Keywords: Vaccines, missing data, NRC, guidance
The FDA-commissioned National Research Council (NRC) report on the prevention and treatment of missing data in clinical trials, and the recent EMA guideline on missing data, might be expected to have implications for the way truncated immunogenicity data is analyzed in clinical trials. Classically, single imputation methods have been used for imputing values less than the lower limit of quantitation ( |
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC
